Saline antitrust claims are “quite implausible”, judge says
A judge has dismissed without prejudice claims that Baxter and Hospira conspired to increase the price of intravenous saline solution by falsely recalling the product and depleting the saline inventory nationwide.
Subscribe to Global Competition Review
Subscribe and start reading now
Already have access? Login below
Copyright © Law Business ResearchCompany Number: 03281866 VAT: GB 160 7529 10